MAP2K7 and neoplasm: Future research involving the use of 18F-FDG-PET/CT imaging may investigate the effect of reduction in hypermetabolic tumor mass (by using molecular-targeted therapy [BRAF-/MEK-inhibitors], radiation therapy, and/or surgery) prior to the initiation of treatment with ICI therapy on outcome.